Patents by Inventor ERIC PUJADE-LAURAINE

ERIC PUJADE-LAURAINE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating homologous recombination deficient cancer
    Patent number: 11970530
    Abstract: This disclosure relates to methods of treating homologous recombination (HR) deficient cancers, such as ovarian cancer, fallopian tube cancer, primary peritoneal cancer, breast cancer, and/or pancreatic cancer. This disclosure further relates to preventing, controlling or reducing hypertension and/or proteinuria in a subject receiving a therapeutically effective amount of bevacizumab therapy.
    Type: Grant
    Filed: August 11, 2021
    Date of Patent: April 30, 2024
    Assignee: ASTRAZENECA AB
    Inventors: Tsveta Petrova Milenkova-Ilieva, Eric Pujade-Lauraine, Isabelle Ray-Coquard
  • METHODS OF TREATING HOMOLOGOUS RECOMBINATION DEFICIENT CANCER
    Publication number: 20220048983
    Abstract: This disclosure relates to methods of treating homologous recombination (HR) deficient cancers, such as ovarian cancer, fallopian tube cancer, primary peritoneal cancer, breast cancer, and/or pancreatic cancer. This disclosure further relates to preventing, controlling or reducing hypertension and/or proteinuria in a subject receiving a therapeutically effective amount of bevacizumab therapy.
    Type: Application
    Filed: August 11, 2021
    Publication date: February 17, 2022
    Inventors: TSVETA PETROVA MILENKOVA-ILIEVA, ERIC PUJADE-LAURAINE, ISABELLE RAY-COQUARD